Written on: January 22, 2025 by SprayTM
BC3 Technologies, a privately held medical device company, announced that its SEAL Hemostatic Spray—an aerosolized chitosan for management of serious arterial bleeding—can now be used by Maryland EMS clinicians to help stop blood loss fast.
In December 2024, the Maryland Institute for Emergency Medical Services Systems (MIEMSS) declared all FDA-approved/FDA-cleared chitosan- or kaolin-based hemostatic agents will be permitted in Maryland for the purposes of hemorrhage control.
“We recognize that hemorrhage control for injured patients is of paramount importance,” said Timothy Chizmar, MD, State EMS Medical Director, MIEMSS.
“Whether the bleeding is controlled with a gloved hand, gauze, or a tourniquet, every minute counts for the patients.”
While some bleeding can be controlled by hand or gauze, many wounds prove to be more challenging to manage. MIEMSS and other groups of experts in trauma surgery and emergency medicine reviewed hemostatic agents in various forms including powder and spray that are currently available to the EMS community.
“MIEMSS examined our research, along with deployments internationally, and provided products to the University of Maryland Shock Trauma Center,” shared Wayne Grube, CEO & Co-Founder, BC3 Technologies
“They analyzed the data from our studies and FDA clearance documents, validated our products, and informed MIEMSS that SEAL was acceptable for trauma care in Maryland,” he added.
Since the hemostatic agent may be embedded in gauze or packaged in another form (e.g. spray or gel), all Maryland EMS clinicians now have consent to utilize SEAL Hemotastic Wound Spray as part of their protocols to stop blood loss fast.
“Maryland is leading the way in improving patient outcomes by seeing SEAL as the innovative breakthrough that will save lives. With a Maryland EMS deployment, we are encouraging others to follow,” shared Grube.
SEAL Hemostatic Would Spray is the first and only FDA-cleared aerosolized chitosan for rapid management of serious arterial bleeding, according to the company. Marking a significant advancement in emergency medical response and trauma care, SEAL is a patent-pending product that acts as a strong physical barrier, effectively and quickly sealing wounds to stop blood flow within seconds.
Unlike bandage or granule-based chitosan products, SEAL can be applied under windy and wet conditions and in low-light. The product is compact, easy to carry, and can be administered by first responders, professional medical staff, military, patients or caregivers. SEAL Pro is available as a 2.5 oz single use spray and SEAL OTC a 1.5 oz single use spray. BC3 Technologies offers First Aid Only First Aid Kit with SEAL and MOLLE Pouches with tourniquet and trauma shears.
